-
1
-
-
70849137218
-
Drug interactions in oncology: How common are they?
-
Riechelmann RP, Del Giglio A. Drug interactions in oncology: how common are they?. Ann Oncol. 2009 ; 20: 1907-1912
-
(2009)
Ann Oncol
, vol.20
, pp. 1907-1912
-
-
Riechelmann, R.P.1
Del Giglio, A.2
-
2
-
-
0037414162
-
Drug-drug interactions among elderly patients hospitalized for drug toxicity
-
Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. J Am Med Assoc. 2003 ; 289: 1652-1658
-
(2003)
J Am Med Assoc
, vol.289
, pp. 1652-1658
-
-
Juurlink, D.N.1
Mamdani, M.2
Kopp, A.3
Laupacis, A.4
Redelmeier, D.A.5
-
3
-
-
34247231457
-
Proposal for a new tool to evaluate drug interaction cases
-
Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007 ; 41: 674-680
-
(2007)
Ann Pharmacother
, vol.41
, pp. 674-680
-
-
Horn, J.R.1
Hansten, P.D.2
Chan, L.N.3
-
4
-
-
58149229547
-
Antiepileptic drugs in the treatment of neuropathic pain: Drug-to-drug interaction in elderly people
-
Lordos EF, Trombert V, Vogt N, Perrenoud JJ. Antiepileptic drugs in the treatment of neuropathic pain: drug-to-drug interaction in elderly people. J Am Geriatr Soc. 2009 ; 57: 181-182
-
(2009)
J Am Geriatr Soc
, vol.57
, pp. 181-182
-
-
Lordos, E.F.1
Trombert, V.2
Vogt, N.3
Perrenoud, J.J.4
-
6
-
-
0345283330
-
Physicians' decisions to override computerized drug alerts in primary care
-
Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003 ; 163: 2625-2631
-
(2003)
Arch Intern Med
, vol.163
, pp. 2625-2631
-
-
Weingart, S.N.1
Toth, M.2
Sands, D.Z.3
Aronson, M.D.4
Davis, R.B.5
Phillips, R.S.6
-
7
-
-
2442433545
-
Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
-
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004 ; 140: 795-801
-
(2004)
Ann Intern Med
, vol.140
, pp. 795-801
-
-
Nebeker, J.R.1
Barach, P.2
Samore, M.H.3
-
8
-
-
84865470107
-
New ABDA database classification of interactions showing the way through the interactions jungle
-
Zagermann-Muncke P. New ABDA database classification of interactions showing the way through the interactions jungle. PharmZtg. 2009 ; 2: 25-16
-
(2009)
PharmZtg
, vol.2
, pp. 25-16
-
-
Zagermann-Muncke, P.1
-
9
-
-
0008922584
-
-
(accessed January 2009 and October 2010)
-
Thomson Reuters. 'DRUGDEX System', http://www.micromedex.com/products/ drugdex/ (accessed January 2009 and October 2010).
-
Drugdex System
-
-
Thomson, R.1
-
10
-
-
0037380880
-
Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol
-
Suzuki A, Yasui-Furukori N, Mihara K, et al. Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. Ther Drug Monit. 2003 ; 25: 192-196
-
(2003)
Ther Drug Monit
, vol.25
, pp. 192-196
-
-
Suzuki, A.1
Yasui-Furukori, N.2
Mihara, K.3
-
12
-
-
70450206025
-
Pharmacokinetic drug interactions in palliative care: Focus on opioids
-
Strouse TB. Pharmacokinetic drug interactions in palliative care: focus on opioids. J Palliat Med. 2009 ; 12: 1043-1050
-
(2009)
J Palliat Med
, vol.12
, pp. 1043-1050
-
-
Strouse, T.B.1
-
13
-
-
58149242547
-
Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods
-
Grime KH, Bird J, Ferguson D, Riley RJ. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods. Eur J Pharm Sci. 2009 ; 36: 175-191
-
(2009)
Eur J Pharm Sci
, vol.36
, pp. 175-191
-
-
Grime, K.H.1
Bird, J.2
Ferguson, D.3
Riley, R.J.4
-
14
-
-
41549127146
-
Actual and potential drug interactions associated with methadone
-
Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Med. 2008 ; 9: 315-344
-
(2008)
Pain Med
, vol.9
, pp. 315-344
-
-
Weschules, D.J.1
Bain, K.T.2
Richeimer, S.3
-
16
-
-
34548443321
-
The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice
-
Murtagh FE, Chai MO, Donohoe P, Edmonds PM, Higginson IJ. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice. J Pain Palliat Care Pharmacother. 2007 ; 21: 5-16
-
(2007)
J Pain Palliat Care Pharmacother
, vol.21
, pp. 5-16
-
-
Murtagh, F.E.1
Chai, M.O.2
Donohoe, P.3
Edmonds, P.M.4
Higginson, I.J.5
-
17
-
-
77952228203
-
Implications of opioid analgesia for medically complicated patients
-
Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010 ; 27: 417-433
-
(2010)
Drugs Aging
, vol.27
, pp. 417-433
-
-
Smith, H.1
Bruckenthal, P.2
-
19
-
-
78649503393
-
Case report: Delirium due to a diltiazem-fentanyl CYP3A4 drug interaction
-
e649-648 e610
-
Levin TT, Bakr MH, Nikolova T. Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction. Gen Hosp Psychiatr. 2010 ; 32: 648 e649-648 e610
-
(2010)
Gen Hosp Psychiatr
, vol.32
, pp. 648
-
-
Levin, T.T.1
Bakr, M.H.2
Nikolova, T.3
-
20
-
-
38049041555
-
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl
-
Saari TI, Laine K, Neuvonen M, Neuvonen PJ, Olkkola KT. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Eur J Clin Pharmacol. 2008 ; 64: 25-30
-
(2008)
Eur J Clin Pharmacol
, vol.64
, pp. 25-30
-
-
Saari, T.I.1
Laine, K.2
Neuvonen, M.3
Neuvonen, P.J.4
Olkkola, K.T.5
-
21
-
-
77954156991
-
Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain
-
Leppert W. Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab. 2010 ; 11: 494-506
-
(2010)
Curr Drug Metab
, vol.11
, pp. 494-506
-
-
Leppert, W.1
-
22
-
-
0031839871
-
The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers
-
Wilder-Smith CH, Hufschmid E, Thormann W. The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers. Br J Clin Pharmacol. 1998 ; 45: 575-581
-
(1998)
Br J Clin Pharmacol
, vol.45
, pp. 575-581
-
-
Wilder-Smith, C.H.1
Hufschmid, E.2
Thormann, W.3
-
23
-
-
0031441325
-
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations
-
Markowitz JS, Devine CL. Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations. Ther Drug Monit. 1997 ; 19: 244-245
-
(1997)
Ther Drug Monit
, vol.19
, pp. 244-245
-
-
Markowitz, J.S.1
Devine, C.L.2
-
24
-
-
67649133619
-
Over-the-counter medications and cancer patients: Growing awareness of drug-drug interactions
-
Hanigan MH. Over-the-counter medications and cancer patients: growing awareness of drug-drug interactions. Expert Opin Drug Metab Toxicol. 2009 ; 5: 105-107
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 105-107
-
-
Hanigan, M.H.1
-
25
-
-
73349121627
-
Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study
-
Kobata Y, Yajima H, Yamao J, Tanaka Y, Fukui H, Takakura Y. Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study. Mod Rheumatol. 2009 ; 19: 629-636
-
(2009)
Mod Rheumatol
, vol.19
, pp. 629-636
-
-
Kobata, Y.1
Yajima, H.2
Yamao, J.3
Tanaka, Y.4
Fukui, H.5
Takakura, Y.6
-
26
-
-
78650630989
-
Adverse drug reactions and drug interactions in analgesic therapy
-
Bertsche T, Mikus G. Adverse drug reactions and drug interactions in analgesic therapy. Ther Umsch. 2011 ; 68: 19-26
-
(2011)
Ther Umsch
, vol.68
, pp. 19-26
-
-
Bertsche, T.1
Mikus, G.2
-
27
-
-
33947596046
-
Update on the role of non-opioids for postoperative pain treatment
-
Schug SA, Manopas A. Update on the role of non-opioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol. 2007 ; 21: 15-30
-
(2007)
Best Pract Res Clin Anaesthesiol
, vol.21
, pp. 15-30
-
-
Schug, S.A.1
Manopas, A.2
-
28
-
-
0036271240
-
Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: Comparison with acetaminophen and diclofenac
-
Sanchez S, Martin MJ, Ortiz P, Motilva V, Alarcon de la Lastra C. Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac. Dig Dis Sci. 2002 ; 47: 1389-1398
-
(2002)
Dig Dis Sci
, vol.47
, pp. 1389-1398
-
-
Sanchez, S.1
Martin, M.J.2
Ortiz, P.3
Motilva, V.4
Alarcon De La Lastra, C.5
-
29
-
-
42649093814
-
Potential drug interactions in cancer patients receiving supportive care exclusively
-
RiechelmannRPZimmermannCChinSN. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage2008; 35: 535-543.
-
(2008)
J Pain Symptom Manage
, vol.35
, pp. 535-543
-
-
Riechelmann, R.P.1
Zimmermann, C.2
Chin, S.N.3
-
30
-
-
33745315683
-
Update on guidelines for the treatment of chronic musculoskeletal pain
-
Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin Rheumatol. 2006 ; 25 (Suppl 1). S22-29
-
(2006)
Clin Rheumatol
, vol.25
, Issue.SUPPL. 1
, pp. 22-29
-
-
Schnitzer, T.J.1
-
31
-
-
0027456560
-
Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states
-
Friedel HA, Fitton A. Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs. 1993 ; 45: 548-569
-
(1993)
Drugs
, vol.45
, pp. 548-569
-
-
Friedel, H.A.1
Fitton, A.2
-
32
-
-
84865451146
-
Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs
-
(accessed 4 April 2011)
-
TreudlerRPohleKSimonJC. Flupirtine is a safe alternative drug in patients with hypersensitivity to NSAIDs. Eur J Clin Pharmacol2011; 00: 1-3 (accessed 4 April 2011).
-
(2011)
Eur J Clin Pharmacol
, vol.0
, pp. 1-3
-
-
Treudler, R.1
Pohle, K.2
Simon, J.C.3
-
33
-
-
0000195185
-
The 20 essential drugs in palliative care
-
Dickerson D. The 20 essential drugs in palliative care. Eur J Palliat Care. 1999 ; 6: 130-135
-
(1999)
Eur J Palliat Care
, vol.6
, pp. 130-135
-
-
Dickerson, D.1
-
34
-
-
77949470479
-
Management of refractory breathlessness in patients with advanced cancer
-
Simon ST, Bausewein C. Management of refractory breathlessness in patients with advanced cancer. Wien Med Wochenschr. 2009 ; 159: 591-598
-
(2009)
Wien Med Wochenschr
, vol.159
, pp. 591-598
-
-
Simon, S.T.1
Bausewein, C.2
-
35
-
-
68849089462
-
Comparative tolerability of newer agents for insomnia
-
Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf. 2009 ; 32: 735-748
-
(2009)
Drug Saf
, vol.32
, pp. 735-748
-
-
Zammit, G.1
-
36
-
-
0023902538
-
A sleep laboratory evaluation of the long-term efficacy of zopiclone
-
Fleming JA, Bourgouin J, Hamilton P. A sleep laboratory evaluation of the long-term efficacy of zopiclone. Can J Psychiatr. 1988 ; 33: 103-107
-
(1988)
Can J Psychiatr
, vol.33
, pp. 103-107
-
-
Fleming, J.A.1
Bourgouin, J.2
Hamilton, P.3
-
37
-
-
33749353523
-
Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers
-
Vlase L, Leucuta A, Farcau D, Nanulescu M. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers. Biopharm Drug Dispos. 2006 ; 27: 285-289
-
(2006)
Biopharm Drug Dispos
, vol.27
, pp. 285-289
-
-
Vlase, L.1
Leucuta, A.2
Farcau, D.3
Nanulescu, M.4
-
38
-
-
61349192144
-
Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine
-
Braun M, Cawello W, Boekens H, Horstmann R. Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine. Br J Clin Pharmacol. 2009 ; 67: 209-215
-
(2009)
Br J Clin Pharmacol
, vol.67
, pp. 209-215
-
-
Braun, M.1
Cawello, W.2
Boekens, H.3
Horstmann, R.4
-
39
-
-
0019917839
-
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic
-
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs. 1982 ; 24: 360-400
-
(1982)
Drugs
, vol.24
, pp. 360-400
-
-
Brogden, R.N.1
Carmine, A.A.2
Heel, R.C.3
Speight, T.M.4
Avery, G.S.5
-
40
-
-
27744576368
-
Antidepressant drug-drug interaction profile update
-
Ereshefsky L, Jhee S, Grothe D. Antidepressant drug-drug interaction profile update. Drugs R D. 2005 ; 6: 323-336
-
(2005)
Drugs R D
, vol.6
, pp. 323-336
-
-
Ereshefsky, L.1
Jhee, S.2
Grothe, D.3
-
41
-
-
48549093980
-
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
-
Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008 ; 30: 1206-1227
-
(2008)
Clin Ther
, vol.30
, pp. 1206-1227
-
-
Spina, E.1
Santoro, V.2
D'Arrigo, C.3
-
42
-
-
0033810675
-
Metabolism of the antidepressant mirtazapine in vitro: Contribution of cytochromes P-450 1A2, 2D6, and 3A4
-
Stormer E, von Moltke LL, Shader RI, Greenblatt DJ. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4. Drug Metab Dispos. 2000 ; 28: 1168-1175
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 1168-1175
-
-
Stormer, E.1
Von Moltke, L.L.2
Shader, R.I.3
Greenblatt, D.J.4
-
43
-
-
79551555754
-
Current concepts in the management of opioid-induced constipation
-
Walters JB, Montagnini M. Current concepts in the management of opioid-induced constipation. J Opioid Manag. 2010 ; 6: 435-444
-
(2010)
J Opioid Manag
, vol.6
, pp. 435-444
-
-
Walters, J.B.1
Montagnini, M.2
-
44
-
-
77958484639
-
NSAID-induced gastrointestinal and cardiovascular injury
-
Ng SC, Chan FK. NSAID-induced gastrointestinal and cardiovascular injury. Curr Opin Gastroenterol. 2010 ; 26: 611-617
-
(2010)
Curr Opin Gastroenterol
, vol.26
, pp. 611-617
-
-
Ng, S.C.1
Chan, F.K.2
-
45
-
-
0028582182
-
Steroids and peptic ulcer: An end to the controversy?
-
Gotzsche PC. Steroids and peptic ulcer: an end to the controversy?. J Intern Med. 1994 ; 236: 599-601
-
(1994)
J Intern Med
, vol.236
, pp. 599-601
-
-
Gotzsche, P.C.1
-
46
-
-
1542540024
-
Management of intractable, cirrhotic ascites with an indwelling drainage catheter
-
Reisfield GM, Wilson GR. Management of intractable, cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003 ; 6: 787-791
-
(2003)
J Palliat Med
, vol.6
, pp. 787-791
-
-
Reisfield, G.M.1
Wilson, G.R.2
-
47
-
-
70449706438
-
A comprehensive review of the loop diuretics: Should furosemide be first line?
-
Wargo KA, Banta WM. A comprehensive review of the loop diuretics: should furosemide be first line?. Ann Pharmacother. 2009 ; 43: 1836-1847
-
(2009)
Ann Pharmacother
, vol.43
, pp. 1836-1847
-
-
Wargo, K.A.1
Banta, W.M.2
-
48
-
-
68349111750
-
Provision of palliative care for chronic heart failure inpatients: How much do we need?
-
Harding R, Beynon T, Hodson F, et al. Provision of palliative care for chronic heart failure inpatients: how much do we need?. BMC Palliat Care. 2009 ; 8: 8
-
(2009)
BMC Palliat Care
, vol.8
, pp. 8
-
-
Harding, R.1
Beynon, T.2
Hodson, F.3
-
49
-
-
66249108231
-
Palliative care in heart failure: A position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
-
Jaarsma T, Beattie JM, Ryder M, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 ; 11: 433-443
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 433-443
-
-
Jaarsma, T.1
Beattie, J.M.2
Ryder, M.3
-
50
-
-
0025731996
-
Antidepressant treatment and side effect considerations
-
Tollefson GD. Antidepressant treatment and side effect considerations. J Clin Psychiatry. 1991 ; 52: 4-13
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 4-13
-
-
Tollefson, G.D.1
-
51
-
-
44949197754
-
Interventions for noisy breathing in patients near to death
-
Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev. 2008 ;: CD005177
-
(2008)
Cochrane Database Syst Rev
, pp. 005177
-
-
Wee, B.1
Hillier, R.2
-
52
-
-
42649119796
-
Death rattle: Its impact on staff and volunteers in palliative care
-
Wee B, Coleman P, Hillier R, Holgate S. Death rattle: its impact on staff and volunteers in palliative care. Palliat Med. 2008 ; 22: 173-176
-
(2008)
Palliat Med
, vol.22
, pp. 173-176
-
-
Wee, B.1
Coleman, P.2
Hillier, R.3
Holgate, S.4
-
53
-
-
33644909875
-
Clinically relevant drug interactions with antiepileptic drugs
-
Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006 ; 61: 246-255
-
(2006)
Br J Clin Pharmacol
, vol.61
, pp. 246-255
-
-
Perucca, E.1
-
54
-
-
0030925252
-
In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam
-
Nims RW, Prough RA, Jones CR, et al. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab Dispos. 1997 ; 25: 750-756
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 750-756
-
-
Nims, R.W.1
Prough, R.A.2
Jones, C.R.3
-
55
-
-
0030339215
-
Use-dependent regulation of GABAA receptors
-
Barnes EM. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol. 1996 ; 39: 53-76
-
(1996)
Int Rev Neurobiol
, vol.39
, pp. 53-76
-
-
Barnes, E.M.1
-
56
-
-
60349092371
-
Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: An isobolographic analysis
-
Dudra-Jastrzebska M, Andres-Mach MM, Sielski M, et al. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. Eur J Pharmacol. 2009 ; 605: 87-94
-
(2009)
Eur J Pharmacol
, vol.605
, pp. 87-94
-
-
Dudra-Jastrzebska, M.1
Andres-Mach, M.M.2
Sielski, M.3
-
57
-
-
64849092311
-
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery
-
Oifa S, Sydoruk T, White I, et al. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. Clin Ther. 2009 ; 31: 527-541
-
(2009)
Clin Ther
, vol.31
, pp. 527-541
-
-
Oifa, S.1
Sydoruk, T.2
White, I.3
-
58
-
-
45549095381
-
Caring for the treatment-experienced breast cancer patient: The pharmacist's role
-
Barbour SY. Caring for the treatment-experienced breast cancer patient: the pharmacist's role. Am J Health Syst Pharm. 2008 ; 65: S16-22
-
(2008)
Am J Health Syst Pharm
, vol.65
, pp. 16-22
-
-
Barbour, S.Y.1
|